Vol 12, No 6 (2016)
Review paper
Published online: 2017-06-02
Page views 362
Article views/downloads 680
Get Citation

Connect on Social Media

Connect on Social Media

Is cetuximab in combination with irinotecan as a third-line treatment for advanced colorectal cancer scientifically justified?

Magdalena Krakowska1, Rafał Czyżykowski1, Piotr Potemski1
DOI: 10.5603/OCP.2016.0016
Oncol Clin Pract 2016;12(6):205-208.

Abstract

Not available

Article available in PDF format

Purchase Subscription